No Data
No Data
No Data
No Data
No Data
GlaxoSmithKline Announces Strong Q1 and Positive 2024 Outlook
TipRanksMay 1 03:03 ET
GlaxoSmithKline (GSK.US) Q1 Results Exceed Expectations and Raises Full-Year Profit Guidelines
The Zhitong Finance App learned that GlaxoSmithKline (GSK.US) announced the first quarter results on Wednesday. According to the data, the company's Q1 revenue was 7.36 billion pounds (9.18 billion US dollars), up 10% year-on-year at a fixed exchange rate (CER), higher than market expectations of £7.07 billion; earnings per share were 43.1 pence, which was also higher than market expectations of 37.3 pence. GlaxoSmithKline raised its full-year profit guidance and said sales in the first half of this year will be higher than in the second half due to strong market demand for its respiratory virus and shingles vaccines. The pharmaceutical company currently predicts that in 2024
Zhitong FinanceMay 1 02:40 ET
Express News | Glaxosmithkline Sues Pfizer and BioNTech Over Mrna Technology Patents in Covid-19 Vaccines - US Court Filing
ReutersApr 25 09:18 ET
Analysts Offer Insights on Healthcare Companies: Agilent (A), GlaxoSmithKline (GSK) and Stryker (SYK)
TipRanksApr 17 10:40 ET
Global Anti-Depressant Drugs Market to Register Incremental Growth by 2030, Predicts DelveInsight | Key Companies - AbbVie, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, H. Lundbeck AS, Johnson & Johnson, Pfizer
New York, USA, April 16, 2024 (GLOBE NEWSWIRE) -- Global Anti-Depressant Drugs Market to Register Incremental Growth by 2030, Predicts DelveInsight | Key Companies - AbbVie, AstraZeneca, Eli Lilly and Company,
GlobeNewswireApr 16 13:00 ET
Global Dietary Supplements Market to Grow Immensely by 2030, Predicts DelveInsight | Key Companies - Amway, Abbott, Bayer, Pfizer, Otsuka, GlaxoSmithKline, American Health, Good Health New Zealand
New York, USA, April 10, 2024 (GLOBE NEWSWIRE) -- Global Dietary Supplements Market to Grow Immensely by 2030, Predicts DelveInsight | Key Companies - Amway, Abbott, Bayer, Pfizer, Otsuka, GlaxoSmithKline,
GlobeNewswireApr 10 13:00 ET
No Data
No Data